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Abstract
Background: The Iberian lynx (Lynx pardinus) is considered the most endangered felid species in the world. In order to save
this species, the Spanish authorities implemented a captive breeding program recruiting lynxes from the wild. In this
context, a retrospective survey on prevalence of selected feline pathogens in free-ranging lynxes was initiated.
Methodology/ Principal Findings: We systematically analyzed the prevalence and importance of seven viral, one protozoan
(Cytauxzoon felis), and several bacterial (e.g., hemotropic mycoplasma) infections in 77 of approximately 200 remaining free-
ranging Iberian lynxes of the Don˜ana and Sierra Morena areas, in Southern Spain, between 2003 and 2007. With the
exception of feline immunodeficiency virus (FIV), evidence of infection by all tested feline pathogens was found in Iberian
lynxes. Fourteen lynxes were feline leukemia virus (FeLV) provirus-positive; eleven of these were antigenemic (FeLV p27
positive). All 14 animals tested negative for other viral infections. During a six-month period in 2007, six of the provirus-
positive antigenemic lynxes died. Infection with FeLV but not with other infectious agents was associated with mortality
(p,0.001). Sequencing of the FeLV surface glycoprotein gene revealed a common origin for ten of the eleven samples. The
ten sequences were closely related to FeLV-A/61E, originally isolated from cats in the USA. Endogenous FeLV sequences
were not detected.
Conclusions/Significance: It was concluded that the FeLV infection most likely originated from domestic cats invading the
lynx’s habitats. Data available regarding the time frame, co-infections, and outcome of FeLV-infections suggest that, in
contrast to the domestic cat, the FeLV strain affecting the lynxes in 2007 is highly virulent to this species. Our data argue
strongly for vaccination of lynxes and domestic cats in and around lynx’s habitats in order to prevent further spread of the
virus as well as reduction the domestic cat population if the lynx population is to be maintained.
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Introduction
The Iberian lynx (Lynx pardinus) is native to the Iberian
Peninsula and is considered the most endangered felid species in
the world [1,2,3]. At present this species is especially threatened
due to the decline of its basic prey (the wild European rabbit,
Oryctolagus cuniculus), fragmentation and loss of its habitat, and non-
natural mortality [4]. Iberian lynxes are confined to two isolated
populations in southern Spain in the Don˜ana and Sierra Morena
areas, and only 40–50 and 150–200, respectively, are estimated to
remain [5,6,7]. To save this species from extinction, an EU LIFE
Nature project is underway that includes habitat preservation, lynx
population monitoring, and rabbit population management. In
addition, cryopreservation of lynx genetic material and a captive ex
situ breeding project were initiated to preserve the genetic diversity
of the species and produce new specimens for future reintroduc-
tion. Despite extensive information concerning the field ecology of
this species [8,9,10,11,12,13], only limited information is available
regarding the diseases that affect the Iberian lynx in the wild or in
captivity. Infections due to Cytauxzoon felis (a Theileria-like agent),
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Toxoplasma gondii, hemotropic mycoplasmas, Mycobacterium bovis,
and several parasitic diseases have been described in some
individuals [14,15,16,17,18,19,20,21]. Bovine tuberculosis was
reported as the cause of death for five Iberian lynxes between 1998
and 2007 [22,23,24,25,26,27]. Histopathological studies revealed
generalized immune depletion in these animals, apparently
unrelated to infectious agents or malnutrition [24], and glomer-
ulonephritis [28]. Furthermore, the presence of feline leukemia
virus (FeLV) provirus was recently reported in six samples
originating from both the Don˜ana and Sierra Morena areas in
southern Spain between 1994 and 2003 [29].
A recent study documented the limited genetic diversity of the
Iberian lynx population [30]. Similarly to the cheetahs, where
limited genetic diversity had been shown to be associated with
disease by an otherwise harmless coronavirus [31,32], the
restricted genetic basis of Iberian lynxes may contribute to render
this endangered species particularly susceptible to pathogens and
possibly even to opportunistic infectious agents. Therefore, a
retrospective study, aimed to systematically analyze the prevalence
and importance of known feline pathogens in free-ranging Iberian
lynxes, was initiated. Animals were screened for the following viral
agents: feline herpesvirus (FVH), feline calicivirus (FCV), feline
parvovirus (FPV), feline coronavirus (FCoV), feline leukemia virus
(FeLV), feline immunodeficiency virus (FIV), and canine distem-
per virus (CDV). These viral infections are known to affect also
wild felids [33,34,35]. In addition, animals were tested for C. felis,
Anaplasma phagocytophilum, hemotropic mycoplasmas, Bartonella
henselae, and Chlampydophila felis. Thus, in the present study, we
report on the prevalence of the aforementioned pathogens and we
describe a dramatic FeLV epidemic, which most likely led to the
death of 6 Iberian lynxes within a 6-months period in 2007, its
possible origin, and its relationship to other infectious agents. As a
consequence of this study, we hope to provide insight on how to
reduce danger originating by these infections and to raise public
awareness about the critical situation of the Iberian lynx.
Results
Case history and clinical manifestations
Sixteen of the 77 Iberian lynxes studied died. Seven lynxes were
found dead after being stuck by vehicles, one due to illegal
hunting, and eight died for reasons presumed to be related to
infectious diseases. One of the latter eight lynxes exhibited high
viral loads of CDV, suggesting that CDV infection was the cause
of death (data not shown). In another, young animal, M. bovis was
found in the tracheal wash. One of the animals struck by a vehicle
had been found to be FeLV provirus-positive in 2004. The
remaining six dead lynxes were all positive for FeLV provirus and
FeLV p27 antigen, and all died within six months during the
spring-summer of 2007 in the northern part of the Don˜ana area
(Fig. 1).
In a routine check of animals (n = 16) in this area in early
December 2006, an adult free-ranging male was found to be FeLV
provirus- and p27-positive. The same animal was negative for
FeLV when sampled one year before. This animal demonstrated
no clinical signs and was released. In May 2007, the same lynx was
found dead. In December 2006, the other 15 lynxes from the
northern part of the Don˜ana area were FeLV-negative. Beginning
in March 2007, five of these 15 lynxes died: all five were positive
for FeLV provirus and FeLV p27. In the same period additional
seven lynxes were found to be FeLV-positive and survived. FeLV
p27-positive animals were captured and transported to the Los
Villares rescue center in order to reduce infectious pressure in the
field [36]. Relationships and geographical distribution of the
infected lynxes are depicted in Figure 1. The majority of the
remaining lynxes (n = 61) were clinically healthy.
FeLV infection is associated with increased mortality of
Iberian lynxes
To determine the association of FeLV infection with mortality,
the proportions of FeLV infection in dead and surviving lynxes
were analyzed for significant differences by Fisher’s exact test.
Both, provirus positivity and antigenemia, were significantly
correlated with mortality (pFisher = 0.0138 for provirus;
pFisher = 0.0187 for antigenemia). The significance level even
increased when the traumatic deaths (n = 8) were omitted from
the comparison (pFisher = 0.0007 for provirus; pFisher = 0.0002 for
antigenemia). Provirus positivity was less frequent in lynxes that
died from traumatic reasons than in the total population of the
Don˜ana area (pFisher = 0.041).
Endogenous FeLV sequences
The quantitative real-time PCRs specific for endogenous FeLV
sequences were weakly positive in samples obtained from 5 of 77
lynxes. Four animals tested positive in only one of the three assays
used, one was positive for the enU3-1, enU3-2 and env assays.
However, the enFeLV copy numbers were extremely low, with less
than 1 copy per 10’000 cells, suggesting that the weak positive
results may be the consequence of sequences cross reacting with
the assay.
FeLV and its possible origin in lynxes
Fourteen lynxes (13 from the Don˜ana area and one from Sierra
Morena) tested positive for FeLV-A provirus (Table 1), but negative
for FeLV-B and FeLV-C (data not shown). FeLV provirus was
amplified and sequenced from eleven positive lynxes from the
Don˜ana area. Nucleotide sequence analysis of the surface unit (SU)
of the env gene revealed a common origin for the provirus found in
Don˜ana lynxes in 2007 (99.5–100% identity). The sequences
clustered with and were 97.9–98.2% identical to the FeLV-A/61E
strain (Fig. 2A) [37,38], while the sequence obtained from the lynx
found to be provirus-positive in 2004 (Arena) was only 94.8–95%
identical to the other sequences and was more related to FeLV-A/
Rickard (97.4% identity, Fig. 2A). The predicted amino acid
sequences of the SU glycoprotein from animals infected in 2007
presented an identity/similarity of 97.3–97.6%/98.6–98.9% to
FeLV-A/61E and 95.9–96.2%/97.6–97.8% to FeLV-A/Rickard,
while the identity/similarity of the sequence from the animal
infected in 2004 was 97.3%/98.6% to FeLV-A/61E, 96.2%/97.8%
to FeLV-A/Rickard, and 96.7–97.0%/98.9–99.2% to the 2007
sequences. At the protein level, all sequences from the Iberian lynxes
clustered together with FeLV-A/61E and FeLV-A/Rickard
(Fig. 2B). No sequences showing mutations that could suggest a
close relationship to FeLV-A/61C were found.
Prevalence of other infections
Antibodies to FCV were detected in 29/74 (39.2%), to FPV in 22/
74 (29.7%), to FCoV in 19/74 (25.7%), to CDV in 12/74 (16.2%), to
FHV in 9/74 (12.2%), and to A. phagocytophilum in 4/74 (5.4%)
animals (Table 1). Antibodies to FIV were not detected in any of the
74 samples tested. Eleven out of 75 lynxes tested positive for FeLV
p27 antigen. All FeLV antigenemic lynxes originated from the
Don˜ana area. PCR of blood samples detected FeLV in 14/77
(18.2%), FPV in 2/75 (2.7%), CDV in 1/75 (1.3%), C. felis in 24/77
(31.2%), M. haemofelis in 25/77 (32.5%), ‘Candidatus M. haemomi-
nutum’ in 27/77 (35.1%), ‘Candidatus M. turicensis’ in 10/77 (13%),
Ch. felis in 1/75 (1.3%), and B. henselae in 16/75 (21.3%) samples.
FeLV in Iberian Lynxes
PLoS ONE | www.plosone.org 2 March 2009 | Volume 4 | Issue 3 | e4744
CDV- and FPV-positive animals were found only in the Don˜ana
area, while all C. felis-positive lynxes originated from Sierra Morena.
PCR of all blood samples did not detect FIV, FCoV, FHV, FCV, or
A. phagocytophilum. The detailed results are compiled in Table 1. Fecal
samples tested negative for FCoV (0/68) and positive for FPV in 1/
62 (1.6%) and CDV in 1/45 (2.2%) samples; the latter was obtained
from the only animal in which CDV was found in the blood. Only
six fecal samples from the 14 FeLV provirus-positive animals were
available. Five fecal samples originating from antigenemic animals
tested positive for FeLV DNA, whereas one sample from a p27-
negative animal tested negative by PCR (data not shown).
Association between FeLV and other infectious agents
Statistically significant associations (based on PCR results) were
found between FeLV infection and infections with M. haemofelis
(pFisher = 0.0004) and ‘Candidatus M. turicensis’ (pFisher = 0.0205).
The other pathogens did not show any significant association with
FeLV infection.
Discussion
In view of the endangered situation of the Iberian lynx, the
central government of Spain in conjunction with the autono-
mous government of Andalusia has initiated an ex situ
conservation program comprising captive breeding centers.
Animals that were selected as founders for the captive breeding
project had been caught in the wild and tested for the absence of
pathogens prior to introduction into the captive breeding
program. Of note, some of the founder lynxes were found to
be infected with C. felis, hemotropic mycoplasmas and B. henselae,
and also to exhibit antibodies to other infectious agents.
However, these animals were clinically healthy. Between late
2003 and 2007, substantial information was obtained regarding
the prevalence and importance of infectious agents in Iberian
lynx populations of the Don˜ana and Sierra Morena habitats.
With the exception of FIV, evidence for all tested feline
pathogens was found. Interestingly, the seroprevalence of
FHV, FCV, FPV, and FCoV was substantially higher than that
observed in free-ranging Eurasian lynxes (Lynx lynx) from Sweden
[39]. The increased seroprevalence of these feline pathogens in
Iberian lynxes probably reflects higher population density and
closer contact with domestic cats as compared to lynxes in the
Swedish population. It is clearly desirable that the infectious
pressure by these feline pathogens arising from domestic cats
should be kept as low as possible.
Figure 1. Overview of the geographical distribution and relationships between FeLV-infected lynxes. The regions of Mazago´n, Coto del
Rey and Dehesa Gato (Don˜ana National Park), and of Valquemado (Sierra Morena) are depicted schematically. All animals are identified by names.
Large open arrows indicate migration after birth, accompanied by the year of migration. Symbols indicate females and males. Dead animals are
indicated by a cross ({) accompanied by the year of death. Small arrows indicate descendants of the females, and the birth year is also indicated.
Frames with dashed lines indicate FeLV-infected animals; frames with continuous lines indicate FeLV-infected animals from which the FeLV env genes
were sequenced. Gray shading (animal ‘‘Arena’’) indicates the FeLV variant most distantly related to the other FeLV found in these lynxes. The names
of lynxes having close contact are positioned in close vicinity.
doi:10.1371/journal.pone.0004744.g001
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Before the fall of 2006, FeLV infection (provirus) had been
detected in one animal (‘‘Arena’’) in 2004. In a recently published
retrospective study [29], six of 21 lynxes sampled between 1993
and 2003 were found to be FeLV provirus-positive, but not
antigenemic. Although no clinical data were reported in that
study, there was no indication that FeLV infection would represent
a major risk for the lynx population. This situation changed
acutely when, in 2007, several animals with severe clinical signs
were found to be infected with FeLV and eventually died, the
statistical association between FeLV infection and death being
highly significant. Interestingly, presence of FeLV-provirus in
lynxes that died from traumatic incidents (1 shot, 7 hit by cars) was
significantly lower than in the lynxes with FeLV infection found
dead. From this it was concluded that FeLV provirus positivity was
not a predisposing factor for death by accidents. The pathogenicity
of the FeLV strain involved in the outbreak, with six of 13 infected
animals succumbing within six months, was rather unexpected.
Five of the FeLV-infected lynxes that had died were living in the
Coto del Rey nucleus, where three adult pairs of lynxes and their
offspring normally only use 700–1000 ha [13]. Consequently,
contact between individuals may be frequent in this area [40]. The
other FeLV-positive dead lynx was living in the Gato nucleus,
where animals have relatively high rates of contact with those
living in the Coto del Rey nucleus via dispersal [9]. Several of the
FeLV-infected lynxes showed clinical signs and/or hematologic
abnormalities, such as anemia, lymphopenia or neutropenia,
compatible with FeLV infection also observed in domestic cats. In
contrast, the rapid onset of the clinical signs leading to death are
not a typical feature of FeLV-A infection in cats, where some
FeLV infected animals can survive more than 10 years [41,42].
The presence of co-infections could also have contributed to the
high pathogenicity of FeLV in the lynxes. From the observation
that a significant association exists between FeLV and hemotropic
mycoplasma infections, one is tempted to argue that these co-
infections may lead to increased pathogenicity. However, although
the association is statistically significant, co-infection by FeLV and
hemotropic mycoplasms cannot be the cause of death in all cases,
as all lynxes that survived FeLV infection were also positive for
hemotropic mycoplasms. It is possible that pre-existing infection
by these agents may favor FeLV infection. The increased
frequency of FeLV infection in lynxes positive for hemotropic
mycoplasms could also reflect simultaneous transmission of these
agents with FeLV during cat-to-lynx contact.
Sequencing of the complete FeLV env gene revealed that the
virus present in lynxes affected in 2007 was clearly distinct from
the virus detected in the FeLV-positive lynx found dead in 2004.
This suggests that FeLV was introduced into the Iberian lynx
population on at least two occasions. Nonetheless, all analyzed
FeLV sequences were closely related to FeLV-A and, in particular,
to FeLV-A/61E, a member of a highly conserved family
representing prototype viruses of the horizontally transmitted,
minimally pathogenic FeLV-A. These FeLV-A prototype viruses
are assumed to be present in all naturally occurring FeLV
infections in domestic cats. FeLV-A/61E in conjunction with
FeLV-A/61C was found to cause severe immunodeficiency in
domestic cats (FeLV-FAIDS) and was originally isolated from a cat
in Colorado [43]. Although we were not able to detect envelope
variants similar to FeLV-A/61C in the blood, the presence of
additional FeLV variants in different organs cannot be excluded.
Thus, important minority genomes harboring changes in the env
gene sequence may have been present but were not detected. To
exclude this possibility, we not only sequenced the majority of
FeLV variants present in the peripheral blood, but also cloned
FeLV from four lynxes and analyzed several clones from each
Table 1. Overview of the prevalence of infection in Iberian lynxes.
Don˜ana National Park Sierra Morena
Serology PCR Serology PCR
Pos/Total % Pos/Total % Pos/Total % Pos/Total %
Viral infections
FeLV 11/45* 24.4* 13/45 28.9 0/30* 0* 1/32 3.1
FIV 0/44 0 0/45 0 0/30 0 0/32 0
FCoV 7/44 15.9 0/45 0 12/30 40 0/32 0
FHV 7/44 15.9 0/45 0 2/30 6.7 0/30 0
FPV 13/44 29.5 2/45 4.4 9/30 30 0/30 0
FCV 15/44 34.1 0/45 0 14/30 46.7 0/30 0
CDV 11/44 25 1/45 2.2 1/30 3.3 0/30 0
Protozoan infections
Cytauxzoon felis n.a. n.a. 0/45 0 n.a. n.a. 24/32 75
Bacterial infections
M. haemofelis n.a. n.a. 16/45 35.6 n.a. n.a. 9/32 28.1
C.M. haemominutum n.a. n.a. 13/45 28.9 n.a. n.a. 14/32 43.8
C.M. turicensis n.a. n.a. 6/45 13.3 n.a. n.a. 4/32 12.5
A. phagocytophilum 1/44 2.3 0/45 0 3/30 10 0/30 0
B. henselae n.a. n.a. 6/45 13.3 n.a. n.a. 10/30 33.3
Chlamydopila felis n.a. n.a. 0/45 0 n.a. n.a. 1/30 3.3
FeLV: feline leukemia virus; FIV: feline immunodeficiency virus; FCoV: feline coronavirus; FHV: feline herpesvirus; FPV: feline parvovirus; FCV: feline calicivirus; CDV: canine
distemper virus; M. = Mycoplasma; C.M. = Candidatus Mycoplasma; A. = Anaplasma; B. = Bartonella; * = p27 antigen; n.a. = not applicable.
doi:10.1371/journal.pone.0004744.t001
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animal, without finding additional sequences. In domestic cats
with FeLV-FAIDS, the second virus variant (FeLV-A/61C) was
mainly found in the intestines and was not present in the blood
[37]. Thus, further investigations should include such tissue
samples from infected lynxes. Alternatively, mutations, deletions,
or repeats in other parts of the FeLV genome that were not
characterized in the present study (e.g., in the LTR) could have
contributed to the pathogenicity of the virus. FeLV variants with
21-bp tandem repeats in the LTR have been isolated from
domestic cats with naturally occurring lymphomas and, more
recently, from Florida Panthers [44,45,46]; the LTR transcrip-
tional enhancer repeats were described in T-cell tumors [47].
These 21-bp repeats confer a replicative advantage to the virus
rather than modify the disease spectrum [44,47]; they were not
investigated in the present study.
Furthermore, the high pathogenicity observed in FeLV-infected
Iberian lynxes might be due to the host, rather than solely to viral
factors. The genetic diversity of the Don˜ana lynx population is
lower than that of the Sierra Morena population [30], and
therefore the pathogenic potential of FeLV could have been
enhanced by inbreeding. In addition, an immune-mediated
systemic disease of unknown origin has been recently postulated
[28]. Cheetahs, another wild felid species with reduced genetic
diversity, also demonstrate increased susceptibility to some
infectious disease agents [48]. Endogenous FeLV-related sequenc-
es (enFeLV) could be another host factor that might contribute to
the high pathogenicity of FeLV in lynxes [49,50]. These enFeLV
exist as multiple, nearly full-length proviral sequences (1 to 100
copies/cell) in domestic cats, as well as in closely related wild cats
of the genus Felis, e.g., European wildcats (Felis silvestris silvestris)
[51]. However, endogenous FeLV sequences related to those of
domestic cats are apparently not present in Iberian lynxes: only 5
of the 77 lynxes tested displayed weak signals by quantitative real-
time PCR, which is not compatible with presence of enFeLV
sequences. As endogenous retroviruses are integrated in the germ
line and by consequence should be present in at least one copy per
cell, the results obtained can only be explained by the presence of
either endogenous sequences distantly related to the enFeLV of
domestic cats or of a co-infection with another gammaretrovirus,
both showing a weak cross-reactivity to the real-time PCR systems
used. The absence of FeLV-B, which is the result of a
recombination between exogenous and endogenous FeLV, is also
in agreement with the absence of enFeLV in the Iberian lynxes,
since the incidence of FeLV-B in the domestic cat is usually higher
than 50% in diseased cats [52]. Absence of enFeLV sequences
suggests that the mechanisms inducing disease in lynxes must be
distinct from those in FeLV-B-infected cats.
As only a few cases of FeLV infection were observed prior 2007
[29], it is likely that FeLV infection in lynxes is rare, is not readily
carried within the lynx population, and most likely originates from
domestic cats, which are increasingly frequent in Don˜ana. A FeLV
prevalence of 15.6% was reported in Spanish cats [53]; this might
be even higher around Don˜ana (F. Martinez, personal commu-
nication). Therefore, a higher risk of transmission from domestic
cats to lynxes is likely. Since some FeLV variants seem to be highly
pathogenic in the Iberian lynx, it would seem important for the
survival of lynxes to protect them against further FeLV
transmission from domestic cats. Thus, it is important that FeLV
infection in free-ranging lynxes be controlled as quickly as possible.
To this end, conservation authorities have started to vaccinate
lynxes against FeLV infection using a Canarypox-based FeLV
vaccine [54]. From what is known about the control of FeLV
infection in domestic cats, vaccination is highly effective. Although
vaccination did not induce sterilizing immunity in domestic cats, it
was nonetheless able to stimulate the immune system to a degree
that allowed the cats to overcome the infection rapidly and to clear
most of the viral RNA from the blood [55]. Even if immunization
does not completely protect lynxes against transient infection,
there is justified hope that the outcome of FeLV infection will be
less severe. In addition to vaccination, it is probably also important
to decrease the infectious pressure on lynxes by preventing
domestic cats from entering the lynx habitats and by vaccinating
them against FeLV infection to reduce the risk of FeLV
transmission to lynxes.
Materials and Methods
Animals and samples
From late 2003 until September 2007, EDTA-anticoagulated
blood, serum, and fecal samples from 77 free-ranging Iberian
lynxes were collected in both the Don˜ana (n = 45) and Sierra
Morena (n = 32) areas in the South of Spain. Some of these
animals were later included in the ex situ breeding program. Only
samples collected at the time of capture (free-ranging status) were
included in this study. Blood samples were collected from the Vena
cephalica of animals that had been caught and immobilized with a
mixture of ketamine-medetomidine for radiocollaring, sanitary
checking, allocation to the captive breeding, or other management
programs. Blood or serosanguineous samples were also collected
from the thoracic cavity or the heart of animals found dead.
Nucleic acid extraction from blood, fecal, and tissue
samples
Total nucleic acids (TNA) were extracted from 200 ml of
EDTA-blood, serosanguineous fluid, or fecal samples using the
MagNA Pure LC Total Nucleic Acid Isolation Kit (Roche
Diagnostics, Rotkreuz, Switzerland), or from tissues collected
upon necropsy using DNeasy and/or RNeasy Tissue kits (Qiagen,
Hombrechtikon, Switzerland) according to the manufacturer’s
instructions.
Detection of specific infections
Serological methods. Serum samples from 75 animals were
available for the serological assays. The presence of antibodies
against FHV, FCV, FPV, FCoV, and CDV was determined by an
immunofluorescence assay (IFA), and antibodies to FIV were
detected by ELISA and western blot, as previously described
[33,56]. FeLV p27 antigen was detected and quantified by ELISA as
previously described [57]. Antibodies against A. phagocytophilum were
determined by an immunofluorescence assay using commercially
available IFA slides (VMRD, Inc. Pullman, WA, USA).
Figure 2. Evolutionary relationships of Iberian lynx FeLV SU. The Maximum Parsimony (MP) tree is shown. Trees are drawn to scale; length is
in terms of the number of changes over the entire sequence. (A) Relationships at the DNA level. MP tree length = 643, consistency index = (0.744726),
retention index = (0.827143), composite index = 0.671491 (0.615995) for all sites and parsimony-informative sites (in parentheses). The codon
positions included were 1st+2nd+3rd+Noncoding. There were a total of 1424 base positions in the final dataset, of which 311 were parsimony-
informative. (B) Relationships at the protein level. MP tree length = 253, consistency index = (0.861538), retention index = (0.876712), composite
index = 0.783150 (0.755321) for all sites and parsimony-informative sites (in parentheses). There were a total of 473 amino acid positions in the final
dataset, of which 108 were parsimony informative.
doi:10.1371/journal.pone.0004744.g002
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Detection and quantification of DNA and RNA. DNA
specific for FHV, FPV, FIV, and FeLV provirus, B. henselae, Ch.
felis, A. phagocytophilum, and hemotropic mycoplasmas was detected
and quantified by real-time TaqMan PCR, as previously described
[58,59,60,61,62,63,64,65,66]. The presence of C. felis was detected
by conventional PCR using the forward primer Cytfelis.203f (59-
AGA CCY YAA ACC ATC CCG CT-39) and reverse primer
Cytfelis.423r (59-CCT GCT GCC TTC CTT AGA TG-39)
(Microsynth, Balgach, Switzerland). The PCR reactions contained
2.5 units of Taq DNA Polymerase (Sigma, Buchs, Switzerland), a
final concentration of 500 nM of each primer, 200 mM dNTPs
(Sigma), 2.5 ml of 106PCR Buffer (Sigma), and 2.5 ml of template
in a final volume of 25 ml. An initial denaturation of 5 min at 95uC
was followed by 35 cycles of 95uC for 30 s, 70uC for 45 s, and
72uC for 1 min, with a final extension at 72uC for 10 min on a
Biometra TPersonal thermal cycler (Biolabo, Chatel-St-Denis,
Switzerland).
RNA specific for FCV and FCoV was detected and quantified
by real-time TaqMan RT-PCR, as previously described
[59,67,68]; for CDV the RT-PCR reaction was set up with
12.5 ml of One-step RT qPCR Mastermix Plus (Eurogentec,
Seraing, Belgium), as well as a final concentration of 600 nM each
for the forward primer CDV.78f (59-GGA AGC CTT GAT GAT
AGC ACT GA-39) and reverse primer CDV.161r (59-GCC GAA
AGA ATA TCC CCA GTT-39, Microsynth) and 200 nM for the
fluorogenic probe CDVp (59-6FAM- TCT GGC GAA GAT TAT
TCC GAA GGA AAT GCT-TAMRA-39, Eurogentec). Finally,
5 ml of RNA was used in a 25 ml total reaction volume. Reverse
transcription for 30 min at 48uC was followed by a denaturation
step at 95uC for 10 min and 45 cycles of 95uC for 15 s and 60uC
for 30 s. Real-time PCR and RT-PCR were performed using an
ABI Prism 7700 sequence detection system (Applied Biosystems,
Rotkreuz, Switzerland).
PCR assays used to characterize FeLV infection
Specific FeLV-B and –C subtype detection. FeLV-B was
detected as previously described [69]. For FeLV-C, PCR was
designed to amplify a 2 kb region encoding the envelope and the
39LTR of FeLV-C. The specificity of the system was validated as
described for FeLV-B [69]. The PCR reactions contained 0.4 units
of PhusionTM High Fidelity DNA Polymerase (Finnzymes,
Keilaranta, Finland), final concentrations of 500 nM each for
the forward primer 5944F and reverse primer 8041R (Table 2),
200 nM dNTPs (Sigma), 4 ml 56 PCR HF Buffer (Finnzymes),
and 5 ml of template in a final volume of 20 ml. An initial
denaturation of 30 s at 98uC was followed by 35 cycles of 98uC for
20 s, 64uC for 30 s, 72uC for 2 min, and a final extension at 72uC
for 5 min on a Biometra TPersonal thermal cycler (Biolabo).
Full-length FeLV-A env amplification, subcloning, and
sequencing. TNA from blood or DNA from tissue samples was
used for amplification of the complete FeLV provirus env gene. To
discover specific primers, a multiple sequence alignment (MSA) of
all GenBank FeLV env sequences (available as of June 2006) was
compared with the MSA of endogenous FeLV (enFeLV) and
FeLV-C env entries. Primers that anneal to FeLV-A, but not
enFeLV or FeLV-C, were used (Table 2). MSAs were constructed
using the multiple alignment editor Jalview [70]. The primer
melting temperature and degree of self-annealing were determined
using the GCG software package (Accelrys, San Diego, CA, USA).
For amplification of full env, PCR reactions comprised 0.4 units of
PhusionTM High-Fidelity DNA Polymerase (Finnzymes), final
concentrations of 500 nM each for primers 5617F and 8197R,
200 mM dNTPs, 4 ml of 56 PhusionTM HF Buffer, and 2 ml of
template in a final volume of 20 ml. PCR was performed using a
Biometra Tpersonal PCR thermal cycler (Biolabo). After an initial
denaturation at 98uC for 30 s, amplification was performed using
35 cycles of 98uC for 20 s, 64uC for 30 s, and 72uC for 2 min 30 s,
and a final extension of 72uC for 8 min. PCR products were either
sequenced directly after purification using the GenElute PCR
Clean-Up Kit (Sigma) or separated by agarose gel electrophoresis,
excised from the gel, purified using the GenElute Gel Extraction
Kit (Sigma), and cloned into the pCRII-TOPO vector (Invitrogen,
Basel, Switzerland) according to the manufacturer’s instructions;
the obtained clones were then sequenced. Sequencing was carried
out by Synergene Biotech, Zurich, Switzerland using primers
5617F, 5847F, 6123F, 6123R, 6382F, 6382R, 6956F, 6956R,
7266R, and 8197R (Table 2). The resulting Iberian lynx FeLV-A
env surface glycoprotein (SU) sequences were deposited in the
GenBank database under accession numbers EU293175 to
EU293194. MSAs of Iberian lynx enFeLV and FeLV subtypes
env SU (GenBank Accession Numbers: M18247, M18246,
M12500, AF052723, M14331, AY662447, AB060732, M23025,
M25425, AY354318) were constructed using ClustalW [71] and
refined using T-Coffee [72]. Phylogenetic trees were constructed
using MEGA3 Software [73]. Boostrap support (% of 1,000
bootstrap replicates) was calculated using the neighbor-joining,
minimum evolution, and maximum parsimony methods.
Endogenous FeLV (enFeLV) detection and quantifica-
tion. The enFeLV DNA loads were determined as described
using three different systems (enU3-1, enU3-2, and enEnv) [51]
that detect enFeLV sequences present in the recently annotated
cat genome [74]. A feline glyceraldehyde-3-phosphate
dehydrogenase (fGAPDH) pseudogene, of which one copy is
present in the genomic DNA of feline cells [64], was quantified by
real-time TaqMan PCR assay [75]. Copy numbers of enFeLV
were divided by fGAPDH copy numbers to calculate the number
of copies per cell.
Phylogenetic analyses
Phylogenetic trees were constructed using MEGA3 [73].
Bootstrap support (1000 replicates) was calculated by the
neighbor-joining/minimum evolution/MP methods and consid-
ered significant when .70% [76]. MP trees were obtained using
Table 2. PCR primers used for amplification and sequencing
of FeLV env and for detection of FeLV-B and -C subtypes.
Name Sequence 59-39 Length Ref.
5617F CCTATGGCTCACTTCTTTGATACTGATATCTCTA 34 This paper
5847F ACATATCGTCCTCCTGACCAC 21 [79]
5944F GATCAGGACCTCCCGAACGACCCT 24 [79]
6124F GTAATAACCAATATGCAAACTAACACCC 28 This paper
6124eF ACAATAACCAACCTTGTAACTGGAACAA 28 This paper
6124R GGGTGTTAGTTTGCATATTGGTTATTAC 28 This paper
6382F TGGGGCCAAAGGGAACACAT 20 This paper
6382R ATGTGTTCCCTTTGGCCCCA 20 This paper
6956F CGAAGGGATTGCAATCTTAGGTAAC 25 This paper
6956R GTTACCTAAGATTGCAATCCCTTCG 25 This paper
7266R TGTGTACACATATTCGGGTTGATGGTA 27 This paper
8041R CCTAACTTCCTTATATCTCATGGGAACATGT 31 This paper
8197R GAAGGTCGAACCCTGGTCAACT 22 [79]
All primers were synthesized by Microsynth, Balgach, Switzerland.
doi:10.1371/journal.pone.0004744.t002
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the Close-Neighbour-Interchange algorithm [77] with search level
3 [76], in which initial trees were obtained by random addition of
sequences (10 replicates). All alignment gaps were treated as
missing data. Branch lengths were calculated using the average
pathway method [77].
PID (percent identity/similarity)
PID values for DNA and predicted protein sequences were
calculated using the software package MatGAT (Matrix Global
Alignment Tool) version 2.02 [78].
Statistical analyses
To assess associations between FeLV and other infectious
agents, infection frequencies were compared using the Fisher’s
exact test (GraphPad Prism version 3.00 for Windows, GraphPad
Software, San Diego, USA). P-values,0.05 were considered as
significant. Group comparison was performed using Fisher’s exact
test (Analyse-it for Microsoft excel version 2.03, Analyse-it
Software, Ltd., Leeds, UK).
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